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Experiments on the mechanism of pharmacological effects on the central nervous system have led to the discovery of a lack of specificity
of certain enzymes in living cells, which may cause biosyntheses of toxic compounds. R. A. PETERS, who observed this phenomenon
during his experiments on the toxic effects of fluoroacetate, called it "lethal synthesis". Similar observations can also be made, if
antimetabolites of nicotinamide are used, because the lack of specificity of a nucleosidase (NADP-glycohydrolase EC 3.2.2.6) within the
endoplasmatic reticulum of the brain cells leads to the biosynthesis of pyridine nucleotides which slow down or completely inhibit the
hydrogen transfer between enzyme and substrate of different oxidoreductases. If 3-acetylpyridine is administered to rats in a dose of
80 mg/kg, the formation of nucleotides containing 3-acetylpyridine is the cause of different neurological deficiency symptoms, which in-
clude convulsive fits occurring at intervals and permanent disturbances of nervous functions, such as hyperkinesis and ataxic gait.
The long lasting deficiency symptoms, which can frequently be shown for more than one year, can be considered as pathobiosis in the
sense of the definition given by HEUBNER.
In isolated brain microsomes, containing a high nucieosidase activity, the synthesis of the dinucleotide phosphate (3-acetylpyridine
adenine dinucleotide phosphate) is greater than that of the dinucleotide in the same time and under the same conditions. Spectrofluorometric
examinations of brains of rats which had received 3-acetylpyridine also confirmed this preferred biosynthesis of 3-APADP in vivo. The
compound was identified in all the brain sections examined, but the highest values were found in the hippocampus of the rat. During
the examination of NADP-dependent enzymes the discovery was made, that probably the pentose phosphate cycle is especially con-
cerned. Thereby lower reduction equivalents than in normal cells are made available for the maintenance of the metabolism during the
same time unit. The activity of NADP-dependent enzymes of the pentose phosphate cycle is not the same in all brain regions. During
the examination of the glucose 6-phosphate dehydrogenase (EC 1.1.1.49) the highest turnover rates were found in the hippocampus.
The kinetics of the malic enzyme (EC 1.1.1.40) discovered by OCHOA are modified in a very peculiar manner, the reaction from malate to
pyruvate with 3-APADP acting as hydrogen acceptor being much faster than with the natural coenzyme. The reverse reaction — py-
ruvate to malate — was greatly slowed down in presence of 3-APADPH2. 3-APADP can also act as inhibitor- in presence of NADP, if
more than 50% of the natural coenzyme is present as the derivative of 3-acetylpyridine.
For the comprehension of the long lasting effects of 3-acetylpyridine on the central nervous system, the diminution of the function of
the folic acid reductase (EC 1.5.1.3) is probably of importance. Examinations of the RNA-polymerase (EC 2.7.7.6) of the brain nuclei and
mitochondria showed that, in principle, an interference with the function of this system is possible. There are certain indications that the
biochemical basis of pathobiotic effects induced by drugs is found in disturbances of the function of the cell nucleic acid systems and of
protein synthesis. The analysis of the products of metabolism of 3-acetylpyridine has shown that, except for the product of reduction
3-methylcarbinol, no other metabolite can be made responsible for the causation of the central nervous disturbances.
Untersuchungen über den Mechanismus pharmakologischer Wirkungen im Zentralnervensystem haben zu der Entdeckung mangelnder
Spezifitäten bestimmter Enzyme in lebenden Zellen geführt, die Synthesen zellschädigender Verbindungen verursachen können. R. A.
, PETERS, der solche Befunde bei seinen Arbeiten über die toxische Wirkung von Fluoracetat erheben konnte, nannte diesen Vorgang eine
„tödliche Synthese". Ähnliche Beobachtungen können auch bei der Verwendung von Antimetaboliten des Nicotinsäureamids gemacht
werden, weil die mangelnde Spezifität einer Nucleosidase (NADP-Glykohydrolase EC 3.2.2.6) im endoplasmatischen Reticulum der
Gehirnzellen zur Biosynthese von Pyridinnucleotiden führt, die den Wasserstofftransport zwischen Enzym und Substrat verschiedener
^ Oxydqreduktasen verlangsamen oder vollständig hemmen. Wenn 3-Acetylpyridin in einer Dosis von 80 mg/kg an Ratten verabreicht
tf
 wird, so ist die Bildung von 3-Acetylpyridin enthaltenden Nucleotiden die Ursache verschiedener neurologischer Ausfallserscheinungen,
* zu denen in Intervallen auftretende Krampfanfälle und kontinuierlich bestehende Störungen nervöser Funktionen wie Hyperkinesen und
$ ataktischer Gang gehören. Die lang anhaltenden, oft mehr als ein Jahr nachzuweisenden Ausfallserscheinungen können als Pathobiose
£ im Sinne der von HEUBNER gegebenen Definition angesehen werden.
v Isolierte Mikrosomen des Gehirns, die eine hohe Nucleosidaseaktivität enthalten, synthetisieren mehr 3-Acetylpyridin-adenin-dinucleo-
& tidphosphat in der gleichen Zeit und unter gleichen Bedingungen als 3-Acetylpyridin enthaltende Analoge des NAD. Spektrofluoro-
£ metrische Untersuchungen des Gehirns von Ratten, die 3-Acetylpyridin erhalten haben, bestätigten diese bevorzugte Biosynthese von
?3 3-APADP auch in vivo. Die Verbindung wurde in allen untersuchten Gehirnabschnitten nachgewiesen, doch fanden sich die höchsten
Werte im Hippocampus der Ratte. Bei der Untersuchung NADP-abhängiger Enzyme wurde festgestellt, daß der Pentose-Phosphat-
Cyclus wahrscheinlich besonders betroffen ist. Dadurch werden in der gleichen Zeiteinheit weniger Reduktionsäquivalente als in normalen
,, Zellen für die Aufrechterhaltung des Stoffwechsels zur Verfügung gestellt. Die Aktivität NADP-abhängiger Enzyme des Pentose-Phos-
# phat-Cyclus ist nicht in allen Hirnregionen gleich. Bei der Untersuchung der Glucose-6-phosphatdehydrogenase (EC 1.1.1.49) wurden die
höchsten Umsätze im Hippocampus gefunden.
*] i) These experiments have been supported by a grant by the Deutsche Forschungsgemeinschaft.
f 2) Nach Gastvorlesungen im Department of Biochemistry, University of Oxford/Großbritannien am 5. Juni 1967 und im Department
^ of Neurobiochemistry, Columbia University, New York/USA am 12. Oktober 1967.
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Die Kinetik des von OCHOA entdeckten „malic enzyme" (EC 1.1.1.40) wird in sehr eigenartiger Weise verändert, wobei der Umsatz von
Malat zu Pyruvat mit 3-APADP als Wasserstoffakzeptor schneller verläuft als mit dem natürlichen Coenzym. Die Umkehr der Reaktion —
Pyruvat zu Malat — war in Gegenwart von 3-APADPH2 extrem verlangsamt. 3-APADP kann auch in Gegenwart von NADP als Hemm-
stoff wirken, wenn mehr als 50% des natürlichen Coenzyms als Derivat des 3-Acetylpyridins vorliegen.
Für das Verständnis der lang anhaltenden Wirkungen von 3-Acetylpyridin auf das Zentralnervensystem ist die Herabsetzung der Funktion
der Folsäurereduktase (EC 1.5.1.3) wahrscheinlich von Bedeutung. Untersuchungen der RNA-Polymerase (EC 2.7.7.6) der Gehirnkerne
und Mitochondrien ergaben, daß ein Eingriff in die Funktion dieses Systems grundsätzlich möglich ist. Es bestehen gewisse Hinweise
dafür, daß die biochemische Basis einer durch Pharmaka erzeugten pathobiotischen Wirkung auf Funktionsstörungen des Nucleinsäure-
systems der Zellen bzw. der Proteinsynthese beruht. Die Analyse der Stoffwechselprodukte des 3^Acetylpyridins hat ergeben, daß mit
Ausnahme des Reduktionsproduktes 3-Methylcarbinol kein anderer Metäbolit für die Erzeugung der zentralnervösen Störungen in Frage
kommt.
The analysis of central nervous functions by the use
of pharmacological methods has led to the significant
result, that there are marked differences in each of the
regions of the central nervous system, as far as their
sensitivity to chemical substances is concerned. De-
pending on the chemical structure and efficacy of the
chemical compounds, gradually increasing doses not
only produce therapeutically useful reactions but
frequently also reversible or irreversible damage
within the same cells. For this reason, the selective
vulnerability of certain cerebral regions is of special
theoretical and practical significance, because the
examination of chemically induced neurological
disturbances can furnish important information for
the recognition of the pathogenesis of neurological
diseases. Until now, however, the mechanism of such
disturbances of cerebral function could only in a few
cases be completely elucidated at a molecular level.
Successful research into these problems is rendered
more difficult by the great variations within the mor-
phological structure of the brain. The best example
is still given by the elucidation of the irreversible
inactivation of acetylcholinesterase by organophos-
phorus compounds.
There is no doubt that —as a consequence of its limited
permeability — the blood-brain-barrier can inhibit the
uptake of noxious substances into certain cerebral
regions. The methods of autoradiography, however,
have more and more proved the fact, that several
chemical compounds can be accumulated to a con-
siderable extent within the individual cells of the brain.
The accumulation of a chemical substance within a
certain cerebral region does not implicitly mean that
this substance will produce its greatest activity there.
The accumulation of a drug gains special interest,
whenever it affects the metabolism of the cells con-
cerned, gives rise to enzymic dysfunctions, and these in
turn are the real cause of more serious damage.
Studies of the chemical basis of pharmacological ac-
tions of drugs have also led to the discovery of a pe-
culiar lack of specificity of certain enzymes, thus
enabling living cells to synthesize harmful substances.
This is not in accordance with the general opinion on
the strongly specific function of enzymes. The first
observation of the lack of specificity of important
enzymes in intermediary metabolism was contributed
by R. A. PETERS (1) in the course of his studies on the
toxic action of fluoroacetate. The term "lethal syn-
thesis" used by R. A. PETERS (1) in his Crooniän
Lecture before the Royal Society to define this process
is very well justified, because the animals died of the
metabolic disturbances within the mitochondria of
the brain, developing generalized convulsions and
apnea.
In this case the chemical basis of drug action is rel-
atively simple and clear. Far more difficult to analyze
are, of course, those effects, the chain of reactions of
which is longer, thereby preventing a clear-cut
survey. This especially holds for effects of the more
chronic type which are characterized by irreversibility
or a slow restoration of the functional impairment.
During the experiments we carried out on the effects
of antimetabolites of nicotinamide, we observed special
kinds of central nervous disturbances which, in the
German scientific literature, are generally being re-
ferred to as pathobiosis.
The term was introduced by WOLFGANG HEUBNER (2)
in 1922, while addressing the Göttingen Scientific
Society. He used the term "pathobiosis" to define a
characteristic form of long lasting toxic effects of
drugs in living tissues. In general, he used this term for
all disturbances of cell functions ranging from fully
reversible to irreversible ones which do not entail an
entire necrosis of cells. He also included the different
degrees of deviations from normal, the duration of
which need not be linked with the presence of a drug.
The chronic effects after acute intoxication, the long
lasting effects of X-rays, the production of malignant
tumors by carcinogenic substances and the teratogenic
properties of certain drugs may be classified as patho-
biosis.
Although many experiments have been made to ex-
plain the chemical basis of pathobiotic effects induced
by drugs especially in the central nervous system, our
knowledge is as yet very poor. During the past few
years we have carried out studies on antimetabolites of
nicotinamide and have been able to look into the
biochemical mechanism of such an effect. These ob-
servations also gave information for better under-
standing of the selective vulnerability of certain regions
oof the brain.
By means of this example I shall later try to define the
mechanism of "pathobiosis" as it may be understood
today from the pharmacological point of view. The
antimetabolite of nicotinamide by means of which I
shall first explain this principle, is 3-acetylpyridine. Its
structure very much resembles that of nicotinamide
(Hg.l).
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Fig. 1
Chemical Structures of Nicotinamide (I) and 3-AcetyIpyridine (II)
The drug was injected into the rat at a dose level of
80 mg/kg. After a latent period of 2 to 3 hours, intoxica-
tion gradually increased and during this time the effect on
the central nervous system became markedly evident.
After a period of paralysis a condition of excitement
gradually developed which was made evident by
constant rolling cramps and by massive loss of equi-
librium. At this stage some of the animals died. Among
the survivors, chronic effects were evident which may
be seen as hyperkinesis, disturbance of muscular
coordination with ataxia and at intervals tonic cramps.
The disorientation of motions revealed, that each
movement of a limb is carried out twice in a nearly
regular rhythm, only after a reaction which resembles
an uncertain wiping motion. The rat places the paw
firmly on the surface and this produces an insecure
staggering movement. Occasionally the animals move
with stiff legs. In addition, between the attacks of
cramps which appear spontaneously without visible
cause, the animals show abnormal behaviour. The
rats tremble in panic and try to .evade by scrambling
backwards. Hereby a heavy tremor of the forelegs with
fibrillation of the muscles may occur. The animals
survived these effects on the central nervous system
caused by a single injection of 3-acetylpyridine for
several months or sometimes for more than a year.
If more common criteria are to be used to explain the
disturbances, we can distinguish between symptoms
which appear as attack at intervals and those that occur
continuously with losses of general nervous function.
Electroencephalographic studies reveal definite patho-
logical changes. 4 hours after application of 3-acetyl-
pyridine a general increase in the amplitude of the
EEG waves is found, which show rhythmical and
generalized seizure charges.
To begin with, I should like to talk on the biochemical
basis of this intoxication. KAPLAN and his team (3, 4)
during their investigations proved that 3-acetylpyridine
can be exchanged for nicotinamide in NAD and NADP
by the action of a nucleosidase (NADP-glycohydro-
lase, EC 3.2.2.6). This enzyme, besides being capable
of hydrolysing, also has transferase activity, which,·
however, is not specific. Thus by an erroneous action
compounds resembling nicotinamide, such as 3-acetyU
pyridine, may be transferred to adenosine diphosphate
ribose.
The nucleosidase is almost exclusively present in the
endoplasmatic reticulum of the cell. It cleaves only the
oxidized pyridine nucleotides between the ribose and
the nitrogen of the pyridine derivative. The reduced
compounds are not split, as first shown by MC!LWAIN
and RODNIGHT (5 a, b).
It is possible that the positively charged nitrogen of
the oxidized pyridine compound reacts with an active
centre on the nucleosidase. Figure 2 shows the scheme
of hydrolysis and the exchange of nicotinamide for
acetylpyridine. Following the linkage of NAD(P) to
the enzyme, a hydrolysis in nicotinamide and adenos-
ine diphosphate ribose will take place. Nicotinamide is
an inhibitor of this reaction, so that the hydrolysis is
slowed down with growing concentration of free
nicotinamide. The exchange reaction will remain
untouched, and adenosine diphosphate ribose can serve
as acceptor for 3-acetylpyridine and nicotinamide. The
concentration of 3-acetylpyridine should at least be
10 times higher than that of nicotinamide for the
synthesis to occur. The competitive antagonism will
explain, why the onset of the toxic symptoms can also
Exchange /
Hydrolysis ^^{
(P)
E + NARPPRA
(P)
E + 3-APRPPRA
(P)
-RPPRA +
E — RPPRA
(P)
E + RPPRA
+ NA
+ 3-AP
Fig. 2
Hydrolysis of NAD(P) and Synthesis of 3-APAD(P) by Nucleosidase(Glycohydrolase) from the Endoplasmatic Reticulum
be prevented in vivo by the early injection of nico-
tinamide. The scheme shows, that the lack of speci-
ficity of the nucleosidase also allows the synthesis of
abnormally structured nucleotides. The synthesis pre-
sumes, that unchanged NAD or NADP are available.
The final hydrolytic cleavage of adenosine diphos-
phate ribose from the enzyme at the same time ends the
transfer reaction.
A 3-acetylpyridine derivative of NAD was first isolated
from tumors by KAPLAN, GOLDIN, HUMPHREYS, CIOTTI
and VENDITTI (6). Assays carried out by the same
investigators to demonstrate the same substance in
the brain were unsuccessful. This failure might have
been due to the fact, that the method employed by
KAPLAN was not suitable. In 1962 we were able to
isolate a nucleotide containing 3-acetylpyridine from
the brain of intoxicated animals (COPER and HERKEN) (7).
This substance was purified by chromatography and
identified by spectrophotometric and enzymic proce-
dures. But, the amount was so small that it was im-
possible to ascribe the loss of the neurological functions
to .the activity of this substance. Only 4 to 6% of the
natural NAD was converted into the compound
containing 3-acetylpyridine. In addition the substance
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acted as hydrogen acceptor and donor with different
dehydrogenases so that a severe inhibition of the
metabolism by this nucleotide is unlikely.
In isolated brain microsomes, containing high nu-
cleosidase activity, the synthesis of the dinucleotide
phosphate (3-acetylpyridine adenine dinucleotide phos-
phate) is greater than that of the dinucleotide in the
same period and under similar conditions (BRUNNE-
MANN, COPER and HERKEN) (8) (Fig. 3).
30
Biosynthesis
of 3-APAD
20
1f)
Biosynthesis
of 3-APADP
30
mm
60
Fig. 3
Hydrolysis of NAD(P) and Synthesis of 3-APAD(P) by Nucleosidase(Glycohydrolase) from Brain Microsomes (0.1 M 3-AP)
Δ Δ Hydrolysis of NAD
^ ^ Hydrolysis of NADP
ο ο Synthesis of 3-APAD
• · Synthesis of 3-APADP
The presence of 3-APADP in the brain cells of the
intoxicated animals was difficult to prove for two
reasons:
1) The concentration of Ν ADP in the brain is 15 to
20 times lower than that of NAD.
2) The sensitivity of the methods used was not suf-
ficient for the determination of the quantity of the
nucleotides containing 3-acetylpyridine present in the
special regions of the brain in the presence of the
naturally occurring coenzyme.
LoWRY, ROBERTS and ΚΑΡΡΗΑΉΝ (9) developed a highly
sensitive spectrofluorometric method for the deter-
mination of NAD (NADP) in concentrations of
ΙΟ"11 mol/m/. It is based upon the treatment of the
nucleotides with ON NaOH. It cannot be applied to
the identification of nucleotides containing 3-acetyl-
pyridine, as these nucleotides do not fluoresce under
these conditions. BURGH, STORWICK, BICKNELL, KUNG,
ALEJO, EVERHARDT, LOWRY, KING and BESSEY (10)
found that still more intensive fluorescence reactions
can be produced by addition of methyl ethyl ketone.
Applying this method for the fluorometric determi-
nation of 3-APAD, 3-APADP, and 3-acetylpyridine,
we found that with acetone as well as with methyl
ethyl ketone fluorescent compounds can be produced
which clearly differ from the nucleotides NAD, NADP
and 1-methylnicotinamide.
Amongst the ketones tested (acetone, methyl ethyl
ketone, phenyl methyl ketone, acetylacetone) methyl
ethyl ketone has proved to be the most efficient. During
5· 10
mm at 100°C
Fig. 4.
Dependence of the APAD-(APADP)-Fluorescence on the Quantity
of Methyl Ethyl Ketone (a), of the Base Concentration (b), of the
Incubation Time in Alkaline Medium (c), and of the Acid Concentra-
tion (d). 3.3 μζ APAD have been employed. (HERKEN and NEU-
HOFF) (11)
these experiments the following observations were made
(Fig. 4): methyl ethyl ketone only yields a fluorescent pro-
duct with 3-APAD (3-APADP) in presence of NaOH.
The optimal reaction is obtained with 0.1 ml IN base
and remains unchanged up to concentrations of ?N
NaOH (Fig. 4b). immediate heating of the thoroughly
shaken reaction mixture for 7 min at 100° C will pro-
duce a more intensive fluorescence than longer in-
cubation at lower temperatures. A maximum fluores-
cence will be obtained by subsequent addition of 1 to
2 m/ SN HC1 and by renewed incubation for 5 min at
100° C. An increase of the acid concentration has no
effect (Fig. 4d). The final product of the reaction is
cooled to room temperature, diluted, and measured
in the Aminco-Bowman-spectrofluorometer. The pro-
duct of the reaction must be kept in the dark until it
is measured, as longer exposure to light will cause a
decrease of the fluorescence. The method is highly
sensitive and permits an accurate differentiation of the
natural coenzymes NAD and NADP from the deriv-
atives containing 3-acetylpyridine. Even the presence
of other derivatives of nicotinamide did not interfere
with this method (HERKEN and NEUHOFF) (11).
The excitation spectra of NAD and 3-APAD (3-
APADP) show the differences between the natural and
the abnormally structured products. For those nucleo-
tides which contain 3-acetylpyridine, there is a second
characteristic maximum occurring at a wavelength of
265 nm. The maximum emission is at 500 nm. This
emission is used for the determination of the concen-
tration of the compound in the brain. The high sen-
'sitivity of this method made it possible to demon-
strate the presence of nucleotides containing 3-acetyl-
pyridine up to a range of 2 · 10~12 rnol present in 1 mg
of wet weight of brain cells. This also applies to NADP
and 3-APADP, even when only 1 to 2% of the natural
coenzyme was converted into the compound containing
3-acetylpyridine (Fig. 5) (HERKEN and NEUHOFF) (11).
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Fig. 5
Specific Excitating Spectra of the Reaction Products of 3-APAD(P)(a) and NAD(P) (b) with Methyl Ethyl Ketone
a) 5 · 10-· Moles 3-APAD, 3-fold amplified
b) 5 · 10-· Moles NAD, 35-fold amplified
The derivative of NAD containing 3-acetylpyridine
which is of minor interest, and the natural coenzyme
were destroyed after enzymic hydrogenation with
alcohol dehydrogenase and subsequent treatment with
perchloric acid. During this reaction, the oxidized part
of NADP and also of 3-APADP was retained in the
extract which made possible a quantitative determination
of these nucleotides by the spectrofluorometric me-
thod.
Extraction of the whole brain furnished the surprising
evidence that nearly 40% of naturally occurring NADP
is converted into an abnormally formed compound
containing 3-acetylpyridine. NEUHOFF (12) has found
in our Institute, that the concentration of 3-acetyl-
pyridine in the brain 4 hours after injection is 5 to 10
times higher than that of nicotinamide. The establish-
ment of a concentration gradient against the extracellular
space indicates an active transport of 3-acetylpyridine
through the cell membrane, and the formation of
abnormally structured nucleotides reaches the maximal
value at about the same time. Using spectrofluorometric
methods, it is possible to determine the biosynthesis of
3-APADP within 9 different regions of the brain. In all
of them, the abnormally structured nucleotide was,
however, proved to be present in different concentra-
tions.
We found that the exchange of 3-acetylpyridine with
nicotinamide reaches the maximum value in the NADP
of the hippocampus (Fig. 6). This finding is interesting
for the reason that it possibly explains the observed
neurological disturbances, which occur in certain
intervals as convulsive fits. As is well known, the
hippocampus plays a dominating role for the regulation
of excitation processes in the brain, and this as part of
the limbic system. This probably does not cause the
continuous disturbances of the movements previously
described. They have more to do with the extrapy-
ramidal system.
It is striking, that the amount of NADP as compared
with the controls was not diminished as would be expect-
ed from the formation of 3-APADP, by the exchange of
nicotinamide for 3-acetylpyridine. These deviations can
either be the expression of a change of a redox quotient
in favour of the oxidized form of the nucleotides or
can be due to an additional formation of the abnormal
nucleotide. This has not been investigated.
During the examination of the cell fractions, we ob-
served that almost nothing is formed in the mitochon-
dria, but more than 90% was found in the cytoplasm of
the brain cells which did not include the mitochondria.
Since, according to KLINGENBERG (13) nearly 35% of
the total NADP of the brain cells is present in the
mitochondria, and this is not converted, the proportion
of 3-acetylpyridine adenine dinucleotide phosphate in
the remaining part of the cell increases correspond-
ingly.
The preference for the hippo.campus can also be con-
firmed by autoradiography (HERKEN) (14, 15). After
injection of 14C-labelled 3-acetylpyridine, the strongest
radiation was found in certain definite regions of the
hippocampus. The method used does, however, not
permit more detailed differentiation within the cells.
On the other hand, a comparison with a picture of the
topographic anatomy of the hippocampus makes
evident, that the "stratum pyramidale" and perhaps
the marginal areas of the "stratum oriens" and the
"stratum radiatum" in the regions CA 2 and CA 3 are
o:
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NADP and 3-APADP Content in Different Brain Regions I. Control II. 6—7 hrs after 100 mg/kg 3-AP, Numbers = 3-APADP in % of
3-APAD* T~ NALJ*
Π = NADP = 3-APADP
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Fig. 7
Topographic Drawing of Hippocampus, schematically according to
data published by BLACKSTEAD and ANDERSEN (37, 38)
obviously involved. These are areas which are com-
monly assumed to be metabolically highly active
(Fig-7).
The electron micrograph of the nuclear region of a
pyramidal cell demonstrates clearly, how closely the
nucleus is surrounded by the endoplasmatic reticulum,
in which the NAD- and NADP-nucleosidases are
localized. This can explain the high degree of transfer
reactions in this area. I take this opportunity to thank
Dr. NIKLOWITZ of the Institute for Brain Research of
the Max-Planck-Society, Frankfurt, for his electron
micrograph. The close spatial relationship between
the ergastoplasm and the nucleus probably also permits
the exchange of nucleotides between these cell struc-
tures through the pores of the nucleus, possibly
resulting in a disturbance of the metabolism of the
nucleus (Fig. 8) (NIKLOWITZ and BAK) (16).
What are the consequences of the accumulation of 3^
acetylpyridine dinucleotide phosphate to the metabo-
lism of the brain cell? O. WARBURG (17) has found:
"Die Wirkung der Pyridinnucleotide in der lebendigen
Substanz beruht auf der F higkeit ihres Pyridinanteiles,
zwei Wasserstoffatome zu addieren und diesen Wasser-
Fig. 8
Section of a Pyramidal Cell (Region CA 2) with Nuclear Cap cut
longitudinal
ER(K) = rough endoplasmatic reticulum at head of the nucleus
NM = nuclear membrane
NP = nuclear membrane pore
GoK = Golgi complexes
M = mitochondria
GoB = Golgi vacuole
GrV = granula
magnification: χ 26000 (NIKLOWITZ and BAK) (16)
Stoff wieder abzugeben, also auf der F higkeit, rever-
sible Dihydropyridinverbindungen zu bilden". The
replacement of nicotinamide by 3-acetylpyridine raises
the question, whether there occurs a disturbance of
hydrogen transfer between enzymes and substrates
using pyridine nucleotides as co-factors. Almost noth-
ing was known about the behaviour of 3-APADP in
such systems. There only exists an indication from the
work of KAPLAN, CIOTTI, and STOLZENBACH (4), that
the isocitrate dehydrogenase (EC 1.1.1.42) obtained
from the heart of pigs reacts significantly slower with
this unnatural pyridine nucleotide than with the natural
coenzyme.
Hence, we prepared 3-APADP with the help of micro-
somal enzymes and studied the kinetics of'the hydrogen
transfer in different dehydrogenases in vitro (COPER
and NEUBERT; NEUBERT and COPER; HERKEN and
TIMMLER) (18, 19, 20, 21). The study revealed, that all
NADP-dependent enzymes have a retarded ability for
π π π π πί Π
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Fig. 9
Velocity of Reactions of different Dehydrogenases with 3-APADP(H2)
s Co-Factor, calculated from Lineweaver-Burk-Diagrams
NADP(H2) = 100%
hydrogen transfer, if they are incubated with 3-acetyl-
pyridine adenine dinucleotide phosphate instead of with
the natural coenzyme. While studying the kinetics of
such enzymes COPER and NEUBERT found an exception,
to which I shall refer later on. Yet, there were signi-
ficant differences in the extent to which these reactions
were affected; they are illustrated in Figure 9.
It was of particular interest to note, that the first two
NADP-dependent steps of the pentose phosphate
cycle are involved, and these are important for the
production of the reduced coenzyme. The enzymes
concerned are glucose 6-phosphate dehydrogenase (EC
1.1.1.49) and 6-phosphogluconic acid dehydrogenase
(EC 1.1.1.43). If the first enzymic step of the Warburg-
Dickens-Horecker cycle is reduced to 1/6 of the original
turnover after conversion of NADP into the nucleo^
tide containing 3-acetylpyridine, it will also have
obvious unfavourable consequences on the following
reaction. At the same time, the reduction-equivalents,
which are necessary for the maintenance of normal
cell function, are greatly lowered.
The activity of NADP-dependent enzymes taking part
in the pentose phosphate cycle is not the same in
Z. klin. Chem. u. klin. Biochem./6. Jahrg. 1968/Heft 5
Herken: Functional Disorders of the Brain 363
different brain regions. BRUNNEMANN and COPER
(22) of our Institute have found, that the hippocampus
holds a special position in having the highest turnover
of glucose 6-phosphate dehydrogenase.
The investigation of different enzymes with 3-acetyl·
pyridine adenine dinucleotide phosphate as coenzyme
showed that each reaction which leads to a change in
the redox quotient in favour of the oxidized form of
pyridine nucleotides, will also influence the hydrogen
acceptor system. There is, e. g., a very strong inhibition
of glutathione reductase at different concentrations of
the substrates.
Based on these results, the following scheme can be
drawn up (Fig. 10). At the left, the hydrogen donors
are shown and at the right the hydrogen acceptors. The
diminution of the reduction equivalents by a slow
Enzyme
Oxido -Reductase
Dehydrogenase Reductase
Substrate fasf . +(^Jj£ ) *»/ .
 Subsfrate
H * Dona tor 2 H* Acceptor
slow 3 APADP V slow
preferential impairment of reductases
by 1. deficit in reduction equivalents
2. slower H * transfer to substrates
Fig. 10 -
Schematic Representation of H+-Transfer between Substrate and
Enzyme with NADP and 3-APADP as Co-Factors
hydrogen transfer in presence of 3-APADP as coenzyme
of the dehydrogenase indirectly leads to a reduction of
the efficiency of reductases. This, however, presupposes,
that the mentioned enzymes are directly connected with
each other in one compartment of the cell.
During their investigations concerning the velocity of
the hydrogen transfer between substrate and NADP-
dependent enzymes, NEUBERT and COPER (20), while
-studying the malic enzyme (EC 1.1.1.40) which had
been discovered by OCHOA, obtained some results
which may contribute towards the understanding of the
acute neurotoxicity of 3-acetylpyridine.
The measurement of the kinetics showed that the
reaction from malate to pyruvate, with 3-APADP
acting as hydrogen acceptor, was faster than that with
the natural coenzyme NADP (Fig. 11). As yet, we have
not found this with any other NADP-dependent
enzyme.
The reversal of the reaction, pyruvate to malate, in
presence of 3-APADPH2 was extremely slow. This is
shown on Figure 12.
3-APADP can act as inhibitor in presence of NADP
which entails that the catalysis can also be slowed down
in vivo, if more than 50% of the natural coenzyme is
present as derivative of 3-acetylpyridine. This has e. g.
been proved in the hippocampus (Fig. 13).
—
-
I I
PAOP+\
Fig. 11
"Malic Enzyme"-Reaction (Malate >· Pyruvate) from Rat Brain.
Comparison of reaction rates in the presence of NADP+ or 3-APADP+
COO"
?=°CH3
pyruvate
-3-APADPH+H+
•3-APADP
malate
coo-
HOCH
CH2
COO-
Fig. 12
"Malic Enzyme"-Reaction with NADP(H2) or 3-APADP(H2) asCoenzymes
i l l l l I ι
JLf 1 Ί
M \NADPH2\
6 -101* 8
Fig. 13
Inhibition of the Activity of the "Malic Enzyme" by 3-APADPH2
ο ο NADPHa + 50 μΜ 3-APADPH2 x x NADPH2
•10s
3
-1 1 10
1
-L
M-V* .
Fig. 14
Comparison of FHa Reductase Activities from Rat Brain with NADPH
+ H+ (——) and 3-APADPH + H+ (o—o) as Hydrogen Donator.Transformation of dihydrofolic acid into tetrahydrofolic acid reg-
istered by the decrease in extinction at 340 nm
Measuring cuvette contained: 1 mM MgCl8> 1 ΠΊΜ isocitrate, 0.2m/isocitrate dehydrogenase, a suitable amount of the enzyme prep-
/M phosphate buffer pH 7.5, NADP or 3-APADP in various
concentrations listed on the diagram
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For the understanding of the long lasting effects of
3-acetylpyridine, the conversion of dihydrofolic acid
into tetrahydrofolic acid which is slowed down in
presence of 3-APADP is probably important.
The evaluation of Lineweaver-Burk-diagrams showed
a significant dependence of the reaction velocity of the
enzymic reduction of the folic acid on the amount of
NADPH present (Fig. 14). This reduction was speci-
fically dependent on this pyridine nucleotide; the in-
cubation with NADH was ineffective. The replacement
of the natural coenzyme by the derivative containing
3-acetylpyridine slows down the velocity of the con-
version of FH2 to FH4 to approximately one half of the
natural value. For judging trie process in vivo, it is,
of course, important to resolve the problem, as to
whether the quantities are sufficient to prevent the
activity of natural coenzymes that are still present. The
specific consequences of the above-mentioned reaction
may result in the formation of activated formate and
in the transfer of C 1 units during the biosynthesis of
important products of intermediary metabolism, such
as serine, methionine, choline, and also purines and
pyrimidines. This specificity depends on particular
localization and the degree of synthesis in different
cells of the brain. The de novo synthesis can be of
special importance for those compounds, which cannot
pass the blood-brain-barrier.
After injection of 30 μΟ of 14C-labelled formaldehyde,
distinctly marked regions in the hippocampus have
been found by KUSCHINSKY (23). The greatest activity
is found within the regions CA 2 and CA 3 as well as
in the gyrus dentatus, as can be seen in the hippo-
campus in a survey autoradiograph of the whole brain.
Also in the brain, formaldehyde is evidently utilized in
the synthesis of nucleic acids and proteins. Other
authors, especially RICHTER and his team (24), have
found, that after the application of 14C-labelled glucose,
considerable amounts of the labelled carbon could be
traced in the proteins of the brain cells. Some ex-
periments, which we carried out in the meantime for
the purpose of orientation with uniformly 14C-labelled
glucose, indicate that the synthesis of 3-APADP in the
ganglion cells exerts a lasting influence on such proc-
esses of the metabolism in vivo. 18 hours after in-
toxication only about 60% of the activity, which could
be traced in untreated animals, was found in the proteins
of the cell nuclei.
In order to answer the question whether the symptoms
of deficiency are caused by the incorporation of 3-
acetylpyridine alone, it was important to determine
which metabolites of acetylpyridine are produced in the
organism. Laboratory examinations of the urine have
proved, that no free acetylpyridine is eliminated.
BEHER and his team (25) had already obtained this
result at an earlier date. These experiments performed in
our Institute by NEUHOFF, HARRIS, and K HLER (26,
27) showed that in metabolism numerous compounds
are derived from 3-acetylpyridine; 12 of them could be
isolated and identified. The first metabolites known were
0.0% H 25%
y
CH3
4-5%
APAD and APA DP »· intoxication
-° ^0
^v"Cςτ™'
CH3 A5%
COOH
°H 55·-^  o^
OH Η
10%
0.5-1%
JTA!H3
JiC-OH
CH3
1-2%
XJ,NAD and NADP
Fig. 15
Metabolism of 3-AcetyIpyri dine
(% = "C-excretion in the urine after intraperitoneal application of14C-3-acetyIpyridine)
N-methyl nicotinamide and nicotinic acid. Later on,
pyridine S^methylcarbinol and pyridine 3-methylglycol
followed.
Figure 15 shows all those compounds which could be
isolated and identified from urine after administration
of acetylpyridine. The main product of transformation
seems to be 3-methylcarbinol, produced by reduction;
according to the results of NEUHOFF and K HLER (27),
this product is very quickly glucuronized in the or-
ganism. 35 to 40% of the activity of 14C-labelled 3-
acetylpyridine given by injection was attributed to the
glucuronide. The percentage of the remaining meta-
bolic products may be seen from the figure. Only a
osmall percentage of the applied activity is attributed to
further metabolic products; these are derivatives of
nicotinic acid and nicotinamide, also originating from
3-acetylpyridine.
Of all the pyridine compounds hitherto isolated, only
pyridine methylcarbinol possesses a pharmacological
activity which approximately corresponds to that of
3-acetylpyridine. As far as can be determinedj however,
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the consequences do not seem to be so long lasting.
This compound, too, is transferred into the pyridine
nucleotides of the brain. Among the further com-
pounds which — due to their structure — can be
transferred, 3-acetylpyridine 6-pyridone, and 3-methyl-
carbinol 6-pyridone were entirely non-toxic. According
to our present knowledge, the same applies for pyridine
3-methylcarbinol glucuronide.
There exist basic differences between the biosynthesis
of other acetylpyridine derivatives in vitro and in vivo.
2-Acetylpyridine is not transferred to NADP by the
nucleosidase of the microsomes of the brain, neither in
vitro nor in vivo. In vitro, 4-acetylpyridine is exchanged
for nicotinamide faster than 3-acetylpyridine, so that
considerable quantities of this nucleotide could be
isolated. As was to be expected from the structure, this
compound was ineffective in dehydrogenase- or re-
ductase-systems. A completely contrary observation
was the fact that the toxicity of 4-acetylpyridine is very
low. Symptoms of excitement with generalized con-
vulsions are not seen, even at a dosage of 1 g/kg. The
probable reason for this phenomenon is the assumption,
that 4-acetylpyridine will be changed very quickly in the
metabolism of the liver, or cannot penetrate the cells of
the hippocampus. We could not find any nucleotide
containing 4-acetylpyridine in the brain.
Fig. 16
Archipallium of the Rat after Application of 3-Acetylpyridine
A = astrocytes with hydropic swellings
M = mitochondria
Magnification: χ 42000 LIERSE (32)
Fig. 17
Appendix of Astrocyte near the Vessels with Granular Enclosure (1)
Containing Residual Membranes (arrow). 2 = mitochondria, 3 = basal
membrane. Cerebral cortex of the rat 1 year after intoxication with
3-acetylpyridine. Magnification: χ 58200. LIERSE (32)
Considering the intensity and severity of recognizable
symptoms of intoxication, we would expect a definite
destruction of the morphological structure in certain
zones of the brain. HICKS (28), and also COGGLESHALL
and McLEAN (29, 30) reported microscopically rec-
ognizable lesions in the hippocampus of rats. The
existence of such lesions could neither be confirmed
by McLEAN himself (31) nor by LIERSE (32) and PETERS
(33) who used our experimental animals. Obviously
there is a big difference in the sensitivity of the brain of
different species.
Electron jpiicroscopic studies of the ultrastructure of the
brain after the administration of 3-acetylpyridine
revealed changes mainly in the astrocytes, oligoden-
drocytes, and microglial cells with an enlargement of
the ergastoplasm. It was, however, difficult to interpret
the morphological changes in these animals living one
year after acute intoxication and still showing symptoms
of a defective central nervous system, and convulsions.
In addition to the almost regularly recognizable hy-
dropic swelling of astrocytes (Fig. 16) which might
have resulted as a consequence of convulsions, changes
in the Golgi apparatus were very often noticed.
Homogeneous or granulated particles in the nucleus
and outside were particularly prominent (Fig. 17).
According to LIERSE (32), such particles cannot be
found in such a frequency among normal animals of
similar age.
It is difficult to say, whether these changes are respon-
sible for the long lasting central nervous system symp-
toms. The answer to this question is made more dif-
ficult, because we have to deal with symptoms which,
neurologically, are very different. In the meantime,
further work on histological changes in the brain of die
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rat after 3-acetylpyridine has taken its effect, has been
published; this describes severe lesions of the lower part
of the oliva. They may be responsible for the continuing
disturbances of movement. Also the rolling cramps
which are found during the acute stage of the intoxica-
tion and the observed disorders of balance point to the
fact, that perhaps the medial section of the oliva is also
affected.
These findings do not, however, explain the develop-
ment of the paroxysmal convulsions, which, with
several animals were found still several months and
even 1 year after one single application of 3-acetyl-
pyridine. DENK, HAIDER, KOVAC and STUDYNKA (34)
also noted defects in the ability of learning with the
animals intoxicated with 3-acetylpyridine, but were
unable to obtain sufficient neuropathological evidence
to explain them. It is, therefore, not impossible, that
these symptoms are caused by a special kind of disturb-
ance within the molecular area.
As the synthesis of 3-acetylpyridine adenine dinucleo-
tide is completed after 24 hours, and 3-acetylpyridine at
this time is quantitatively eliminated, it is evident that
during the first 24 hours of intoxication, a metabolic
disturbance is produced bringing about a continuous
reproduction of a biochemical lesion and forming the
cause of pathobiosis. Such an assumption leads us to
look for the cause of the disturbance in the area of
nucleic acid polymerase or of protein synthesis de-
pending on nucleic acid function.
Experiments on the RNA-polymerase (EC 2.7.7.6) of
the brain nuclei and mitochondria, carried out in our
Liver
RNA UNA
Brain
KNA DMA1200
1000
800
^600
200
Fig. 18
Activity of RNA-Polymerase in Isolated Nuclei (·) and Mitochondria(O) of Rat Liver and Brain
Incubation time: 5 min.
The incubation tube contained: 80mM Tris-HCl, 15mM phosphate
buffer pH 8.0; 50 mM KC1; 5 mM MgCl2; 0.5 mM EDTA; 8 mM GSH;0.4 mM ATP, CTP, GTP; 14.8 ^C3H-UTP. Nuclei isolated following
the method of WIDNELL and TATA (36). Mitochondria purified by
sucrose gradient floatation
Fig. 19
Cell Nuclei Isolated from Rat Brain According to the Method of
WIDNELL and TATA (36). The large cell nuclei can be associated with
ganglia cells, the smaller ones with the different types of glia cells.
The cell fraction appears electron microscopically pure. Magnifi-
cation: 8000. MERKER (1967)
Institute by NEUBERT and OBERDISSE (35) show, that
pharmacological changes in two different nucleic acid
systems of the cell are possible. The absolute turnover
of the RNA is much higher in the cell nuclei (Fig.
18).
An electron micrograph shows that the examined
nucleus fraction of the brain is pure (Fig. 19). Mor-
phologically the nuclei are, however, not uniform.
Probably the lighter and bigger cell nuclei come from
ganglion cells and the smaller ones from the glia cells.
We hope to be able to separate these two types from
each other by centrifugation in a density gradient, in
order to facilitate the localization of the lesion.
If the RNA-polymerase activity in the cell nuclei and in
the mitochondria is expressed in terms of the DNA
present, the turnover rate is relatively higher in the
mitochondria than in the nuclei. This is valid for the
liver as well as for the brain. The limitation of the
efficiency of the folic acid reductase (EC 1.5.1.3) can
disturb the synthesis of thymidine, but satisfactory
results on the exchange of thymidine in the DNA of
different brain cells are still lacking. There are, however,
many indications, that the biochemical basis of path-
obiotic action induced by drugs is found in disturb-
ances of the function of the cell nucleic acid systems or
in protein synthesis regulated by messenger RNA.
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Steroide und Haut
7. Mitteilung: Zur Bestimmung verschiedener C19- und Cl%-Steroide in Hauteittaten
Von L. TREIBER und G. W. OERTEL
Aus der Abteilung für Experimentelle Endokrinologie der Universitäts-Frauenklinik
(Direktor: Prof. Dr. V. Friedberg)
(Eingegangen am 16. Januar 1968)
Zur Routine-Analyse verschiedener Cj9- undC18-Steroide in der Haut vom Menschen eluiert man 100 cm2 der Hautoberfläche mit geeigne-
ten Lösungsmitteln, unterwirft den Extrakt nach Entfettung einer Solvolyse und trennt neutrale und phenolische Steroide ab. In der
neutralen Fraktion werden Dehydroepiandrosteron, Androsteron und Atiocholanolon sowie Testosteron mit der 2,4-Dinitrophenyl-
hydrazinmethode, in der phenolischen Fraktion die östrogene durch Gaschromatographie ihrer Acetate quantitativ bestimmt. An Stelle
der üblichen Konzentrationsangaben gibt das Konzentrationsverhältnis einzelner Verbindungen zueinander brauchbare Hinweise auf das
Steroid-Muster der Haut.
Steroids and the skin. Communication No. 1
For the routine analysis of the different C19- and Cjg-steroids in human skin, 100 cm2 of skin surface are eluted with suitable solvents, fats
are removed from the extract, the steroids are redissolved, and the neutral and phenolic steroids are separated. In the neutral fraction,
dehydroepiandrosterone, androsterone, aetiocholanolone and testosterone are quantitatively determined with 2,4-dinitrophenylhydrazine,
and the oestrogen? of the phenolic fraction by gas chromatography of their acetates.
In addition of the usual concentration data, the relative concentrations of the individual compounds are a useful indication of the skin
steroid pattern.
Das Vorkommen von Cl9-Steroiden in der menschlichen
Haut ist seit geraumer Zeit bekannt (1—3). Desweiteren
konnte im Hautgewebe ein Stoffwechsel derartiger
Steroide nachgewiesen werden (4—6), wobei offenbar
das im Kreislauf befindliche Dehydroepiandrosteron-
sulfatid (7) als Vorstufe der durch die Haut ausgeschie-
denen C19- und C18-Steroide gelten dürfte (8).
Aufgrund dieser experimentellen Befunde erschien es
angezeigt, eine Bestimmung verschiedener C19^- und
C-18-Steroide in der Haut vorzunehmen, die gegebenen-
falls auch zur Diagnose Steriod-abhängiger oder -be-
einflußter Hautkrankheiten beitragen könnte.
Methodik
Gewinnung von Hauteluaten
Zur Gewinnung der in der Haut auftretenden freien Steroide,
Steroidsulfatide, -.sulfate (und -glucuronide) wird eine 10 X 10 cm
große Hautfläche oberhalb des Knies mit 10 m/ Äther-Äthanol-
Wasser (1:4:1 v/v) und anschließend mit 10 m/Äthylacetat eluiert.
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